Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 605,482 | 687,816 | 278,590 | 347,684 | 424,439 |
| Marketable Securities | N/A | N/A | N/A | N/A | 7,874 |
| Receivables | 192,008 | 55,367 | 86,888 | 74,578 | 60,363 |
| Inventories | 319,879 | 291,870 | 270,516 | 252,622 | 226,126 |
| Other current assets | 0 | -1 | 0 | 0 | 0 |
| TOTAL | $1,147,958 | $1,070,724 | $675,562 | $721,028 | $760,555 |
| Non-Current Assets | |||||
| PPE Net | 106,818 | 107,235 | 112,042 | 116,348 | 119,739 |
| Investments And Advances | 14,690 | 17,828 | 22,145 | 26,922 | 6,154 |
| Intangibles | 4,359 | 4,515 | 4,508 | 4,670 | 4,783 |
| Other Non-Current Assets | 2,507 | 2,421 | 2,354 | 2,311 | 2,302 |
| TOTAL | $128,374 | $131,999 | $141,049 | $150,251 | $132,978 |
| Total Assets | $1,276,332 | $1,202,724 | $816,611 | $871,279 | $893,533 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 531,891 | 679,639 | 659,759 | 691,241 | 12,150 |
| Accounts payable and accrued liabilities | 104,308 | 82,765 | 107,181 | 102,627 | 102,349 |
| Other current liabilities | 344,877 | 158,447 | 144,813 | 69,953 | 81,258 |
| TOTAL | $982,399 | $921,967 | $912,926 | $867,443 | $213,585 |
| Non-Current Liabilities | |||||
| Long Term Debt | 395,053 | 372,687 | 235,897 | 249,306 | 578,214 |
| Other Non-Current Liabilities | 5,410 | 5,498 | 5,385 | 5,429 | 259,421 |
| TOTAL | $408,317 | $387,770 | $249,513 | $262,427 | $837,635 |
| Total Liabilities | $1,390,716 | $1,309,737 | $1,162,439 | $1,129,870 | $1,051,221 |
| Shareholders' Equity | |||||
| Common Shares | 8,818 | 8,954 | 8,420 | 8,488 | 8,387 |
| Retained earnings | -2,769,851 | -2,801,173 | -2,664,478 | -2,595,775 | -2,464,500 |
| Other shareholders' equity | 1,807 | 919 | 734 | 723 | 622 |
| TOTAL | $-114,385 | $-107,013 | $-345,828 | $-258,591 | $-157,688 |
| Total Liabilities And Equity | $1,276,332 | $1,202,724 | $816,611 | $871,279 | $893,533 |